HuiyiHuiying (HY), a Beijing, China-based medical imaging artificial intelligence (AI) company, closed a strategic investment of undisclosed amount.
The round was led by Intel Capital with participation of Beijing Singularity Power Investment Fund (SPC).
The company intends to use the funds for business development, product innovation and talent recruitment initiatives.
Led by Dr. Xiangfei Chai, Founder and CEO, HY is a medical imaging AI company committed to implementing innovative computer vision and deep learning technologies in the medical sector. The company is collaborating with more than 800 medical institutions in China in clinical applications and scientific research projects, including the Chinese PLA General Hospital, Peking Union Medical College Hospital, Beijing Friendship Hospital and several medical associations.
HY is expanding its business into overseas markets including the United States, Japan, Southeast Asia, India and Europe.
Established in 2015, HY has received investments from CDH, Delta Capital, Bluerun Ventures and Yield Capital.